RxSight, Inc. Tax Credit Carryforward, Valuation Allowance
RxSight, Inc. (RXST) had Tax Credit Carryforward, Valuation Allowance of $6.50 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardValuationAllowance · last filed 2026-02-25
- 2025-12-31: Tax Credit Carryforward, Valuation Allowance $6.50M.
- 2024-12-31: Tax Credit Carryforward, Valuation Allowance $19.10M.
| Period end | Tax Credit Carryforward, Valuation Allowance |
|---|---|
| 2025-12-31 | $6.50M 10-K · filed 2026-02-25 |
| 2024-12-31 | $19.10M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |